Skip to content

Study on Tele-Rehabilitation versus In-Person Pulmonary Rehabilitation for Lung Disease Patients

TELEREHABILITATION VERSUS CENTRE BASED PULMONARY REHABILITATION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: A RANDOMIZED CONTROLLED TRIAL - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081704
Enrollment
28
Registered
2025-03-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J988- Other specified respiratory disorders

Interventions

Intervention1: Community based pulmonary rehabilitation: Duration of 6 weeks 18 sessions three times a week. Control Intervention1: Tele Rehabilitation: Duration of 6 weeks 18 sessions three times a

Sponsors

Centre for physiotherapy and rehabilitation sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Participants must have a definitive diagnosis of idiopathic pulmonary fibrosis based on clinical evaluations, radiological assessments, and histopathological criteria via high-resolution computed tomography (HRCT), pulmonary function tests, following ATS/ERS guidelines and incorporating relevant diagnostic measures (Raghu et al., 2018). b) Subjects must be at least 18 years of age or older. c) Participants must be capable of completing a 6MWT/ISWT for functional assessments that indicate sufficient exercise tolerance. d) Participants should exhibit no significant comorbid conditions that may hinder their involvement in the rehabilitation program, such as severe cardiac issues, uncontrolled diabetes, or recent surgical interventions. e) Patients must possess the cognitive capacity to comprehend and actively engage in the rehabilitation program. f) All participants must have the ability to provide written & oral informed consent.

Exclusion criteria

Exclusion criteria: a) Patients experiencing an acute exacerbation of IPF or significant symptom worsening within the past 4 to 6 weeks. b) Individuals with significant comorbid conditions that could impede participation in the rehabilitation program, including but not limited to severe cardiac diseases, uncontrolled diabetes, or recent major surgeries. c) Individuals currently enrolled in other clinical trials or rehabilitation programs that may interfere with the outcomes of this study. d) Conditions that could hinder the use of tele-rehabilitation, including lack of access to necessary technology (e.g., smartphone, computer, internet connection) or inability to navigate these technologies. e) Showed unwillingness to follow the protocol, f) Unable to speak and/or understand Hindi/English.

Design outcomes

Primary

MeasureTime frame
Forced Vital Capacity (FVC) Forced Expiratory Volume in One Second (FEV1) FEV1/FVC RV TLC RV/TLC Diffusing Capacity for Carbon Monoxide (DLCO) Timepoint: At baseline and at 6 six weeks

Secondary

MeasureTime frame
NATimepoint: NA

Countries

India

Contacts

Public ContactAdila Parveen

Jamia Milllia Islamia

24nadirahmuneer@gmail.com8587868142

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026